T-cell growth factor (TCGF), Lymphokine, IL-2.
Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 133 amino acids and having a molecular mass of 15.4kDa.
The IL-2 is purified by proprietary chromatographic techniques.
T-cell growth factor (TCGF), Lymphokine, IL-2.
APTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFCQSII STLT.
IL-2 is best known for its role in inducing the proliferation of T-cells and natural killer (NK) cells . It also stimulates the growth and differentiation of B cells, lymphokine-activated killer cells, monocytes, macrophages, and oligodendrocytes . Additionally, IL-2 promotes the peripheral development of regulatory T cells (Treg cells), which are essential for maintaining immune tolerance .
The effects of IL-2 are mediated through a trimeric receptor complex consisting of IL-2Rα, IL-2Rβ, and the common gamma chain (γc) . Binding of IL-2 to its receptor initiates signaling cascades involving Jak1, Jak3, Stat5, and the PI3K/Akt pathways .
Recombinant human IL-2 has been used in various clinical settings, particularly in cancer immunotherapy. It has been employed to boost the immune response in patients with metastatic melanoma and renal cell carcinoma . The ability of IL-2 to activate and expand T-cells and NK cells makes it a valuable tool in adoptive cell transfer therapies.
IL-2 continues to be a subject of extensive research, with ongoing studies exploring its potential in treating autoimmune diseases, enhancing vaccine efficacy, and improving the outcomes of immunotherapy . Researchers are also investigating ways to modify IL-2 to reduce its toxicity and enhance its therapeutic benefits.